Diagnostic Accuracy of Pipelle Endometrial Sampling Compared with Hysterectomy Histopathology in Abnormal Uterine Bleeding: A Cross-Sectional Study
DOI:
https://doi.org/10.32007/jfacmedbaghdad3364Keywords:
Abnormal uterine bleeding; , Accuracy; , Endometrial biopsy; , Hysterectomy;, Pipelle.Abstract
Background: The term "abnormal uterine bleeding" refers to abnormalities in the menstrual cycle that include the frequency, regularity, duration and volume of menstrual flow. While it heavily impacts women of reproductive age, abnormal bleeding and postmenopausal hemorrhage remain critical indicators for underlying endometrial pathology across all age groups. The Pipelle endometrial biopsy technique has been used to assess abnormal uterine bleeding. It is used as an outpatient procedure and does not require hospitalization.
Objectives: To accurately assess the diagnostic confirmation role of the Pipelle endometrial biopsy in relation to the final post-hysterectomy histopathology in patients scheduled for hysterectomy because of abnormal uterine bleeding or postmenopausal hemorrhage.
Methods: A cross-sectional study prospectively assessed 70 consecutive patients presenting with abnormal uterine bleeding or postmenopausal bleeding. The cohort included 36 premenopausal women and 34 postmenopausal women, with ages ranging from 28 to 91 years. Between March 1 and December 25, 2023, at Baghdad Teaching Hospital, a Pipelle biopsy was taken and sent for histopathological examination. An analysis of the results was carried out and compared with the results of the hysterectomy specimen of the same patient.
Results: Pipelle biopsy findings revealed that 20 cases (28.6%) had bleeding of endometrial origin, 12 (17.1%) had hyperplasia without atypia, 26 (37.2%) had hyperplasia with atypia and 12 (17.1%) had adenocarcinoma. Compared to hysterectomy-based histopathological findings, the Pipelle biopsy demonstrated a positive predictive value (PPV) and negative predictive value (NPV) of 75% and 85.2% for endometrial hyperplasia without atypia, 25% and 94.1% for endometrial hyperplasia with atypia, and 100% and 75.3% for endometrial adenocarcinoma, respectively. The overall diagnostic accuracy for these three conditions was 83.3%, 68.5%, and 81.4%, respectively.
Conclusion: The Pipelle is safe and accurate to use in the investigation of abnormal uterine bleeding, especially if the histopathological report shows endometrial carcinoma.
Received: 03 May 2026,
Revised: 30 July 2026,
Accepted: 07 Aug. 2026,
Published Online: Aug. 2026
References
. Yesuf A, Molla B, Susu B, et al. Epidemiology and associated factors of abnormal uterine bleeding among reproductive-age women: evidence from Woldia City, Northeast Ethiopia. Sci Rep. 2025 Nov 4;15:38633. https://doi.org/10.1038/s41598-025-22535-9.
2. Munro MG, Critchley HOD, Fraser IS and the FIGO Menstrual Disorders Committee (2018), The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet, 143: 393-408. https://doi.org/10.1002/ijgo.12666.
3. Almuhaitb RA, Alenazi RH, Almebki RA, et al. Management of Abnormal Uterine Bleeding Among Reproductive Age Group Women: A Cross-Sectional Study. J.Clin.Med. 2024; 13(23):7086. https://doi.org/10.3390/jcm13237086.
4. Marnach M, Laughlin-Tommaso S. Evaluation and Management of Abnormal Uterine Bleeding, Mayo Clinic Proceedings. 2019;94(2):326-335. https://doi.org/10.1016/j.mayocp.2018.12.012.
5. Husna UHZ, Khan FI, Khatun Z, et al. Prevalence and Clinical Patterns of Abnormal Uterine Bleeding in Perimenopausal Women: A Study in a Tertiary Care Setting. Journal of Teachers Association. 2025; 38(2):304-310. https://doi.org/10.70818/taj.v38i02.0592.
6. Oncu N, Buhur A, Erkinuresin T. Evaluation of diagnostic accuracy of Pipelle endometrial biopsy using sensitivity and specificity in women with abnormal uterine bleeding. Medicine (Baltimore). 2026 Jan 16;105(3):e47145. https://doi.org/10.1097/MD.0000000000047145.
7. Gupta M, Gupta P, Yadav P. A Randomized Comparative Study to Compare Karman's Cannula and Pipelle Biopsy for Evaluation of Abnormal Uterine Bleeding. Journal of Mid-life Health. 2022;13(1):67-73. https://doi.org/10.4103/jmh.jmh_292_20.
8. ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women with Postmenopausal Bleeding. Obstet Gynecol[Internet].2018May;131(5):e124–9. https://doi.org/10.1097/AOG.0000000000002631.
9. Cooper DB, Menefee GW. Dilation and Curettage. [Updated 2023 May 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK568791.
10. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer. 2006 Feb15;106(4):812–19. https://onlinelibrary.wiley.com/doi/10.1002/cncr.21650.
11. Travaglino A, Raffone A, Saccone G, et al. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria. Histopathology. 2019 Apr 10; 74(5):676–87. https://onlinelibrary.wiley.com/doi/10.1111/his.13776.
12. Terzic MM, Aimagambetova G, Terzic S, et al. Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer. Transl Cancer Res. 2020 Dec; 9(12):7716-7724. DOI: https://doi.org/10.21037/tcr.2020.04.20.
13. Behnamfar F, Arshad E. Diagnostic Values of Pipelle and Standard Curettage Compared to Hysterectomy Pathology in Postmenopausal Bleeding: A Comparative Study. Adv Biomed Res. 2020 Oct 30; 9:58. https://doi.org/10.4103/abr.abr_28_20.
14. Tanko NM, Linkov F, Bapayeva G, et al. Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily Clinical Practice: Why the Approach to Patients Should Be Personalized?. J Pers Med. 2021 Sep 28; 11(10):970. https://doi.org/10.3390/jpm11100970.
15. Mathew SM, Thomas P. A prospective study on the efficacy of Pipelle biopsy to diagnose endometrial pathology in patients with abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2019; 8(11): 4238-4243.
https://doi.org/10.18203/2320-1770.ijrcog20194608.
16. Hansadah S, Balakrishnan D, Sethy M. A Comparative Analysis of the Pipelle Device and Conventional Dilatation and Curettage as Investigative Tools for Abnormal Uterine Bleeding: Assessing Sample Adequacy and Patient Perspectives: A Prospective Observational Cohort Study. Journal of Mid-life Health. 2025; 16(3):278-284. https://doi.org/10.4103/jmh.jmh_13_25.
17. Ilavarasi CR, Jyothi GS, Alva NK. Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding. Journal of Mid-life Health. 2019 Apr-Jun;10(2):75-80. https://doi.org/10.4103/jmh.jmh_109_18.
18. Ordeanu IM, Busuioc CJ, Văduva CC, et al. Obesity as a Catalyst for Endometrial Hyperplasia and Cancer Progression: A Narrative Review of Epidemiology, Molecular Pathways, and Prevention. Biomedicines. 2025;13(11):2612. https://doi.org/10.3390/biomedicines13112612.
19. Moshayedi N, Clair K, Francoeur AA. Obesity management in the setting of endometrial cancer and hyperplasia: A narrative review. Gynecol Oncol Rep. 2025 Oct; 61:101929. https://doi.org/10.1016/j.gore.2025.101929.
20. Wise MR, Jordan V, Lagas A, et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. Am J Obstet Gynecol. 2016 Jun; 214(6):689.e1-689.e17. https://doi.org/10.1016/j.ajog.2016.01.175
Creative Commons Attribution 4.0 International license..
